Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

NCT00046033 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lopinavir/ritonavir
DRUG: Ritonavir
DRUG: Saquinavir
DRUG: Tenofovir disoproxil fumarate
DRUG: Amprenavir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)